Individualizing Neo/Adjuvant Treatment in Early Breast Cancer Care: Education, Tools, and Resources for Patients and Providers

Download All

Review the latest evidence-based strategies on individualized early breast cancer treatment with expert commentaries, online modules, downloadable slidesets, and an Interactive Decision Support Tool that provides personalized management recommendations for treatment selection in early breast cancer.

Resources for your patients:

Denise A. Yardley, MD
Program Director
Kevin Kalinsky, MD, MS


In this commentary, I share my thoughts on the impact of recent data on treatment planning in early breast cancer, including how to incorporate PARP inhibition, CDK4/6 inhibition, and immunotherapy, along with the dilemmas and challenges surrounding their use.

Denise A. Yardley, MD
Program Director
Released: February 22, 2022

Read this expert commentary for an overview of our new treatment decision support tool for HER2 negative early breast cancer, which provides treatment recommendations from 5 breast cancer experts for your patients with HER2 negative early breast cancer.

Kevin Kalinsky, MD, MS Released: September 7, 2022
Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email:

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

Produced in collaboration with
Supported by educational grants from
Merck Sharp & Dohme Corp.

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.


Cookie Settings